Wang Yangwei, Chen Jiaping, Meng Wangyang, Zhao Rong, Lin Wei, Mei Peiyuan, Xiao Han, Liao Yongde
Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Transl Cancer Res. 2023 Feb 28;12(2):273-286. doi: 10.21037/tcr-22-2166. Epub 2023 Feb 6.
Centromere proteins (CENPs) form a large protein family. Sixteen proteins in this family are positioned at the centromere throughout the cell cycle. The overexpression of CENPs is common in many cancers and predicts a poor prognosis. However, a comprehensive analysis of CENPs expression has not been conducted, and their clinical significance in lung adenocarcinoma (LUAD) is unclear.
We investigated the expression differences of the CENP family in LUAD using The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) cohorts. Kaplan-Meier curve survival analysis was performed to assess their independent prognostic values. We then tested 5 clinical LUAD specimens by quantitative real time polymerase chain reaction (qRT-PCR). The risk model was constructed with least absolute shrinkage and selection operator (LASSO). Cox regression analyses were carried out to determine independent prognostic indicators. Weighted gene coexpression network analysis (WGCNA) was employed to define the coexpression networks.
The messenger RNA (mRNA) expression of 15 differential CENP proteins was higher in LUAD than in normal lung tissues. Among them, 10 CENP proteins had significant prognostic value. The risk model comprising , and showed a significant correlation [hazard ratio (HR) 1.75, 95% confidence interval (CI): 1.3-2.35; P=2e-04]. However, the prognostic accuracy was not strong [1-year survival: area under curve (AUC) 0.63; 3-year survival: AUC 0.62; 5-year survival: AUC 0.6]. The qRT-PCR results showed that the 5 CENPs were upregulated in LUAD tissues compared to in normal lung tissues. A total of 441 hub genes coexpressed with the 5 CENPs were identified.
, and have prognostic values and may be potential targets for LUAD treatment.
着丝粒蛋白(CENPs)构成一个庞大的蛋白质家族。该家族中的16种蛋白质在整个细胞周期中都定位于着丝粒。CENPs的过表达在许多癌症中很常见,并预示着预后不良。然而,尚未对CENPs的表达进行全面分析,其在肺腺癌(LUAD)中的临床意义尚不清楚。
我们使用癌症基因组图谱(TCGA)和基因型-组织表达(GTEx)队列研究了LUAD中CENP家族的表达差异。进行Kaplan-Meier曲线生存分析以评估其独立的预后价值。然后,我们通过定量实时聚合酶链反应(qRT-PCR)检测了5个临床LUAD标本。使用最小绝对收缩和选择算子(LASSO)构建风险模型。进行Cox回归分析以确定独立的预后指标。采用加权基因共表达网络分析(WGCNA)来定义共表达网络。
15种差异CENP蛋白的信使核糖核酸(mRNA)表达在LUAD中高于正常肺组织。其中,10种CENP蛋白具有显著的预后价值。由[具体蛋白名称缺失]组成的风险模型显示出显著相关性[风险比(HR)1.75,95%置信区间(CI):1.3 - 2.35;P = 2e - 04]。然而,预后准确性不强[1年生存率:曲线下面积(AUC)0.63;3年生存率:AUC 0.62;5年生存率:AUC 0.6]。qRT-PCR结果显示,与正常肺组织相比,5种CENPs在LUAD组织中上调。共鉴定出441个与5种CENPs共表达的枢纽基因。
[具体蛋白名称缺失]具有预后价值,可能是LUAD治疗的潜在靶点。